Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of 4:00pm ET
 +2.27 / +0.63%
Today’s Change
Today|||52-Week Range
Exactly How Bad Is Regeneron's Latest News?
Oct 26 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical ...
Oct 19 / Zacks.com - Paid Partner Content
3 Key Questions for Amgen Inc. in Q3
Oct 25 / MotleyFool.com - Paid Partner Content
Regeneron & Teva Hit by Clinical Hold on Chronic Pain Study
Oct 18 / Zacks.com - Paid Partner Content
What to Watch in Sanofi's Third-Quarter Results
Oct 24 / TheStreet.com - Paid Partner Content
Ocular's (OCUL) Stock Jumps on Collaboration with Regeneron
Oct 14 / Zacks.com - Paid Partner Content